Calcium Magnesium Butyrate: labelled with incorrect dosage form
Last updated
Summary
Product
Calcium Magnesium Butyrate
Issue
Health products - Labelling
What to do
Consult your health care professional if you have any health concerns.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
Calcium Magnesium Butyrate |
Calcium Magnesium Butyrate |
NPN 80112765 |
Tablet |
600 mg butanoic acid, 80 mg calcium, 40 mg magnesium |
3756 |
Issue
Affected lots are labelled with incorrect dosage form found on the label.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of Recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Natural health products
Companies
BodyBio Inc.
45 Reese Road. Milville NJ, USA 08332
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type III
Identification number
RA-74189
Get notified
Receive notifications for new and updated recalls and alerts by category.